Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 24 von 42

Details

Autor(en) / Beteiligte
Titel
Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy
Ist Teil von
  • Clinica chimica acta, 2018-12, Vol.487, p.299-305
Ort / Verlag
Netherlands: Elsevier B.V
Erscheinungsjahr
2018
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
  • Patients with rheumatoid arthritis (RA) often have reduced muscle mass. Estimated glomerular filtration ratio using the serum cystatin C concentration (eGFRcys) is more accurate than eGFR using the serum creatinine (eGFRcreat) because cystatin C is not influenced by muscle mass, but glucocorticoid therapy may affect serum cystatin C concentration. Fifty patients with RA were included in this study. Renal inulin clearance (Cin) was measured and compared with eGFRcreat, eGFRcys, or the mean of eGFRcreat and eGFRcys (eGFRavg). The mean creatine kinase (CK) concentration was low (36.8 ± 24.4 U/l).The eGFRcreat and eGFRcys regression lines were significantly different from y = x. The mean eGFRcreat value was significantly higher than Cin and that of eGFRcys was lower than Cin. The difference between eGFRcys and Cin was negatively correlated with daily PSL dose. The mean eGFRcys value of patients taking <10 mg PSL was not different from Cin and the eGFRcys regression line was not different from y = x. eGFRcys of patients taking a daily PSL dose ≥10 mg was inaccurate, while eGFRcys was underestimated. eGFRcys was more accurate than eGFRcreat or eGFRavg for patients taking a daily PSL dose of <10 mg. •eGFRcys was more accurate than eGFRcreat or eGFRavg for patients taking a daily prednisolone dose of <10 mg•eGFRcys of patients taking a daily prednisolone dose ≥10 mg was inaccurate•eGFRavg or Ccr × 0.715 is a better approximation than eGFRcys or eGFRcreat for patients taking ≥10 mg PSL daily
Sprache
Englisch
Identifikatoren
ISSN: 0009-8981
eISSN: 1873-3492
DOI: 10.1016/j.cca.2018.10.022
Titel-ID: cdi_proquest_miscellaneous_2120749832

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX